Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

NCT01467401 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: biphasic human insulin

Sponsor

Novo Nordisk A/S